Seagen Inc.
BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS

Last updated:

Abstract:

The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.

Status:
Application
Type:

Utility

Filling date:

25 Jun 2021

Issue date:

27 Jan 2022